52. Mousavifar N, Mirhosseini N. [Association endometrial thickness in third day of menstrual cycle and ovulation]. J Babol Univ Med Sci. 2000;3(7):32-6.
53. Basirat Z, Esmailzadeh S, Jorsaraei SGA, Firoozpour M, Abdolhashempour S. [Determining the best appropriate level of endometrial thickness in the outcome of intra-cytoplasmic sperm injection]. J Babol Univ Med Sci. 2012;14(14):15-21.
54. Finn CA, Martin L. The control of implantation. J Reprod Fertil. 1974;39(1):195-206. www.ncbi.nlm.nih.gov/pubmed/4605229 [
DOI:10.1530/jrf.0.0390195]
55. Bourgain C, Devroey P. The endometrium in stimulated cycles for IVF. Hum Reprod Update. 2003;9(6):515-22. www.ncbi.nlm.nih.gov/pubmed/14714588 [
DOI:10.1093/humupd/dmg045]
56. Hosie MJ, Murphy CR. Clomiphene citrate alters surface ultrastructure of uterine luminal epithelial cells. Acta Anat (Basel). 1992;145(2):175-8. www.ncbi.nlm.nih.gov/pubmed/1441891 [
DOI:10.1159/000147361]
57. Tan SL, Maconochie N, Doyle P, Campbell S, Balen A, Bekir J, et al. Cumulative conception and live-birth rates after in vitro fertilization with and without the use of long, short, and ultrashort regimens of the gonadotropin-releasing hormone agonist buserelin. Am J Obstet Gynecol. 1994;171(2):513-20. www.ncbi.nlm.nih.gov/pubmed/8059833 [
DOI:10.1016/0002-9378(94)90291-7]
58. Trindade CR, Camargos AF, Pereira FE. The effect of buserelin acetate on the uterus of adult rats: morphological aspects. Clin Exp Obstet Gynecol. 2008;35(3):198-201. www.ncbi.nlm.nih.gov/pubmed/18754292
59. Brogden RN, Buckley MM, Ward A. Buserelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical profile. Drugs. 1990;39(3):399-437. www.ncbi.nlm.nih.gov/pubmed/2109679 [
DOI:10.2165/00003495-199039030-00007]
60. Billig H, Furuta I, Hsueh AJ. Gonadotropin-releasing hormone directly induces apoptotic cell death in the rat ovary: biochemical and in situ detection of deoxyribonucleic acid fragmentation in granulosa cells. Endocrinology. 1994;134(1):245-52. http://dx.doi.org/10.1210/endo.134.1.8275940www.ncbi.nlm.nih.gov/pubmed/8275940
61. Kramer B, Magan A, de Wet G. Hyperstimulation affects vascular permeability at implantation sites in the rat endometrium. J Assist Reprod Genet. 1993;10(2):163-8. www.ncbi.nlm.nih.gov/pubmed/8339022 [
DOI:10.1007/BF01207741]
62. Stein B, Kramer B. The effect of exogenous gonadotropic hormones on the endometrium of the rat. J Anat. 1989;164:123-30. www.ncbi.nlm.nih.gov/pubmed/2514174
63. Ertzeid G, Storeng R. The impact of ovarian stimulation on implantation and fetal development in mice. Hum Reprod. 2001;16(2):221-5. www.ncbi.nlm.nih.gov/pubmed/11157810 [
DOI:10.1093/humrep/16.2.221]
64. Rackow BW, Kliman HJ, Taylor HS. GnRH antagonists may affect endometrial receptivity. Fertil Steril. 2008;89(5):1234-9. http://dx.doi.org/10.1016/j.fertnstert.2007.04.060www.ncbi.nlm.nih.gov/pubmed/18410932
65. Jones RE, Lopez KH. Human Reproductive Biology. USA: Elsevier Inc.; 2006.
66. Marcondes FK, Bianchi FJ, Tanno AP. Determination of the estrous cycle phases of rats: some helpful considerations. Braz J Biol. 2002;62(4A):609-14. www.ncbi.nlm.nih.gov/pubmed/12659010 [
DOI:10.1590/S1519-69842002000400008]
67. Ghanadee A, Nasresfahani MH, Behdadipoor Z. [Effects of Nonpulsatile GnRH Agonist Administration on Ovaries of Immature Rats]. Yakhte Med J. 2004;6(23):124-31.
68. Armstrong DT. Alterations of progesterone metabolism in immature rat ovaries by luteinizing hormone. Biol Reprod. 1979;21(4):1025-33. www.ncbi.nlm.nih.gov/pubmed/526499 [
DOI:10.1095/biolreprod21.4.1025]
69. Suszka-Switek A, Czekaj P, Pajak J, Skowronek R, Wrona-Bogus K, Plewka D, et al. Morphological and enzymatic changes caused by a long-term treatment of female rats with a low dose of gonadoliberin agonist and antagonist. Med Sci Monit. 2012;18(8):BR315-30. www.ncbi.nlm.nih.gov/pubmed/22847193
70. Botte MC, Lerrant Y, Lozach A, Berault A, Counis R, Kottler ML. LH down-regulates gonadotropin-releasing hormone (GnRH) receptor, but not GnRH, mRNA levels in the rat testis. J Endocrinol. 1999;162(3):409-15. www.ncbi.nlm.nih.gov/pubmed/10467232 [
DOI:10.1677/joe.0.1620409]
71. Dohler KD, Wuttke W. Changes with age in levels of serum gonadotropins, prolactin and gonadal steroids in prepubertal male and female rats. Endocrinology. 1975;97(4):898-907. http://dx.doi.org/10.1210/endo-97-4-898www.ncbi.nlm.nih.gov/pubmed/1193012
72. Parborell F, Pecci A, Gonzalez O, Vitale A, Tesone M. Effects of a gonadotropin-releasing hormone agonist on rat ovarian follicle apoptosis: regulation by epidermal growth factor and the expression of Bcl-2-related genes. Biol Reprod. 2002;67(2):481-6. www.ncbi.nlm.nih.gov/pubmed/12135885 [
DOI:10.1095/biolreprod67.2.481]
73. Andreu C, Parborell F, Vanzulli S, Chemes H, Tesone M. Regulation of follicular luteinization by a gonadotropin-releasing hormone agonist: relationship between steroidogenesis and apoptosis. Mol Reprod Dev. 1998;51(3):287-94. http://dx.doi.org/10.1002/(SICI)1098-2795(199811)51:3<287::AID-MRD8>3.0.CO;2-Lwww.ncbi.nlm.nih.gov/pubmed/9771649
74. Jelodar GA, Gholami S, Jafarpour F. Effect of GnRH on guinea pig endometrium at preimplantation stage. Indian J Exp Biol. 2007;45(3):242-6. www.ncbi.nlm.nih.gov/pubmed/17373367
75. Fedele L, Marchini M, Bianchi S, Baglioni A, Bocciolone L, Nava S. Endometrial patterns during danazol and buserelin therapy for endometriosis: comparative structural and ultrastructural study. Obstet Gynecol. 1990;76(1):79-84. www.ncbi.nlm.nih.gov/pubmed/2113661